Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2015, Article ID 109158, 8 pages
http://dx.doi.org/10.1155/2015/109158
Research Article

Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome

Department of Cardiology, The Heart Institute of Japan, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 1628666, Japan

Received 22 December 2014; Revised 6 February 2015; Accepted 16 February 2015

Academic Editor: Maurizio Averna

Copyright © 2015 Erisa Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. de Lemos, M. A. Blazing, S. D. Wiviott et al., “Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial,” The Journal of the American Medical Association, vol. 292, no. 11, pp. 1307–1316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. P. Cannon, E. Braunwald, C. H. McCabe et al., “Intensive versus moderate lipid lowering with statins after acute coronary syndromes,” The New England Journal of Medicine, vol. 350, no. 15, pp. 1495–1504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. A. Miettinen and H. Gylling, “Cholesterol absorption efficiency and sterol metabolism in obesity,” Atherosclerosis, vol. 153, no. 1, pp. 241–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. N. R. Matthan, N. Resteghini, M. Robertson et al., “Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial,” The Journal of Lipid Research, vol. 51, no. 1, pp. 202–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. E. Strandberg, R. S. Tilvis, K. H. Pitkala, and T. A. Miettinen, “Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study,” Journal of the American College of Cardiology, vol. 48, no. 4, pp. 708–714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Salen, K. von Bergmann, D. Lütjohann et al., “Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia,” Circulation, vol. 109, no. 8, pp. 966–971, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Grundy, J. I. Cleeman, C. N. Bairey Merz et al., “Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines,” Circulation, vol. 110, no. 2, pp. 227–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Fletcher, K. Berra, P. Ades et al., “Managing abnormal blood lipids: a collaborative approach,” Circulation, vol. 112, no. 20, pp. 3184–3209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Morrone, W. S. Weintraub, P. P. Toth et al., “Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials,” Atherosclerosis, vol. 223, no. 2, pp. 251–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Gagné, H. E. Bays, S. R. Weiss et al., “Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia,” The American Journal of Cardiology, vol. 90, no. 10, pp. 1084–1091, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. A. Gudzune, A. K. Monroe, R. Sharma, P. D. Ranasinghe, Y. Chelladurai, and K. A. Robinson, “Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review,” Annals of Internal Medicine, vol. 160, no. 7, pp. 468–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Ballantyne, R. C. Hoogeveen, J. L. Raya, V. A. Cain, M. K. Palmer, and B. W. Karlson, “Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: results of the GRAVITY randomized study,” Atherosclerosis, vol. 232, no. 1, pp. 86–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  14. T. A. Miettinen, E. H. Ahrens Jr., and S. M. Grundy, “Quantitative isolation and gas—liquid chromatographic analysis of total dietary and fecal neutral steroids,” Journal of Lipid Research, vol. 6, pp. 411–424, 1965. View at Google Scholar · View at Scopus
  15. J. C. LaRosa, S. M. Grundy, D. D. Waters et al., “Intensive lipid lowering with atorvastatin in patients with stable coronary disease,” The New England Journal of Medicine, vol. 352, no. 14, pp. 1425–1435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. D. Waters, C. Brotons, C.-W. Chiang et al., “Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals,” Circulation, vol. 120, no. 1, pp. 28–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Glueck, J. Speirs, T. Tracy, P. Streicher, E. Illig, and J. Vandegrift, “Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives,” Metabolism: Clinical and Experimental, vol. 40, no. 8, pp. 842–848, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Rajaratnam, H. Gylling, and T. A. Miettinen, “Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women,” Journal of the American College of Cardiology, vol. 35, no. 5, pp. 1185–1191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Sudhop, B. M. Gottwald, and K. von Bergmann, “Serum plant sterols as a potential risk factor for coronary heart disease,” Metabolism: Clinical and Experimental, vol. 51, no. 12, pp. 1519–1521, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. Miettinen and H. Gylling, “Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup,” Atherosclerosis, vol. 168, no. 2, pp. 343–349, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Nasu, M. Terashima, M. Habara et al., “Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography,” JACC: Cardiovascular Interventions, vol. 6, no. 7, pp. 746–755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. T. A. Miettinen, H. Gylling, T. Strandberg, and S. Sarna, “Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators,” British Medical Journal, vol. 316, no. 7138, pp. 1127–1130, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Assmann, P. Cullen, J. Erbey, D. R. Ramey, F. Kannenberg, and H. Schulte, “Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 16, no. 1, pp. 13–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Thongtang, J. Lin, E. J. Schaefer et al., “Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients,” Atherosclerosis, vol. 225, no. 2, pp. 388–396, 2012. View at Publisher · View at Google Scholar · View at Scopus